NCT00540748 (oxystudien) is a NA clinical trial of oxytocin in Induced Abortion, sponsored by Asker & Baerum Hospital.

Who is sponsoring NCT00540748?

NCT00540748 is sponsored by Asker & Baerum Hospital.

What drugs are being tested in NCT00540748?

Interventions in NCT00540748: oxytocin.

What condition does NCT00540748 study?

NCT00540748 studies Induced Abortion.

Is NCT00540748 still recruiting?

NCT00540748 is currently completed. Last updated 15 April 2010.

Last reviewed 2010-04-15 · How we verify

NCT00540748: oxystudien

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Is Oxytocin Given During Surgical Procedure for Abortion Before 12 Weeks of Pregnancy Useful ?

Completed NA Last updated 15 April 2010

What this trial tests

NA trial testing oxytocin in Induced Abortion in 400 participants. Completed in 1 December 2009.

Timeline

1 October 2007

Primary endpoint
1 June 2009

1 December 2009

Quick facts

Lead sponsor	Asker & Baerum Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	400
Start date	1 October 2007
Primary completion	1 June 2009
Estimated completion	1 December 2009
Sites	1 location across Norway

Drugs / interventions tested

oxytocin (OXYTOCIN) — full drug profile →

Conditions studied

Induced Abortion — all drugs for Induced Abortion →

Sponsor

Asker & Baerum Hospital

Who can join

Adults 18 to 45, female only, with Induced Abortion. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

blood loss, pain, nausea
Time frame: 2 years

Sponsor's own description

This is a randomized, single-blind study using oxytocin 5U i.v. during surgical abortion in one arm of the study, and no medication in the other arm of the study. Comparison is done between the two groups measuring the following outcomes: pain, nausea and blood loss. The investigators' hypothesis is that there will be no significant differences between the two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of oxytocin

Trials testing the same drug.

NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
NCT06651476 — A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn · Phase 2 · completed
NCT06493968 — Role of Uterotonics in Reducing Intraoperative Blood Loss in Patients With PASD Undergoing Cesarean Hysterectomy · NA · recruiting
NCT05758012 — Carbetocin Compared To Oxytocin During Cesarean Delivery · unknown
NCT05077540 — Oxytocin Versus, Sublingual Misoprostol in the Secondary Prevention of Postpartum Hemorrhage After Vaginal Delivery · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00540748 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Asker & Baerum Hospital
Last refreshed: 15 April 2010

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00540748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing